Rivaroxaban Clonmel 15 mg film-coated tablets Rivaroxaban Clonmel 20 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

rivaroxaban clonmel 15 mg film-coated tablets rivaroxaban clonmel 20 mg film-coated tablets

clonmel healthcare ltd - rivaroxaban; rivaroxaban - film-coated tablet - rivaroxaban

Duloxetine Clonmel 20mg gastro-resistant capsules, hard Ireland - English - HPRA (Health Products Regulatory Authority)

duloxetine clonmel 20mg gastro-resistant capsules, hard

clonmel healthcare ltd - duloxetine - gastro-resistant capsule, hard - 20mg - psychoanaleptics; other antidepressants - duloxetine clonmel is indicated for women for the treatment of moderate to severe stress urinary incontinence (sui)

Imatinib Clonmel 100 mg Film-coated Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

imatinib clonmel 100 mg film-coated tablets

clonmel healthcare ltd - imatinib - film-coated tablet - 100 milligram(s) - other antineoplastic agents - antineoplastic agents, protein kinase inhibitor - imatinib clonmel is indicated in:  paediatric patients with newly diagnosed philadelphia chromosome (bcr-abl) positive (ph+) chronic myeloid leukaemia (cml) for whom bone marrow transplantation is not considered as the first line of treatment.  paediatric patients with ph+ cml in chronic phase after failure of interferon-alpha therapy, or in accelerated phase or blast crisis.  adult patients with ph+ cml in blast crisis  adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) integrated with chemotherapy.  adult patients with relapsed or refractory ph+ all as monotherapy.  adult patients with myelodysplastic/myeloproliferative diseases (mds/mpd) associated with platelet-derived growth factor receptor (pdgfr) gene re-arrangements.  adult patients with advanced hypereosino

Imatinib Clonmel 400 mg Film-coated Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

imatinib clonmel 400 mg film-coated tablets

clonmel healthcare ltd - imatinib - film-coated tablet - 400 milligram(s) - other antineoplastic agents - antineoplastic agents, protein kinase inhibitor - imatinib clonmel is indicated in:  paediatric patients with newly diagnosed philadelphia chromosome (bcr-abl) positive (ph+) chronic myeloid leukaemia (cml) for whom bone marrow transplantation is not considered as the first line of treatment.  paediatric patients with ph+ cml in chronic phase after failure of interferon-alpha therapy, or in accelerated phase or blast crisis.  adult patients with ph+ cml in blast crisis  adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) integrated with chemotherapy.  adult patients with relapsed or refractory ph+ all as monotherapy.  adult patients with myelodysplastic/myeloproliferative diseases (mds/mpd) associated with platelet-derived growth factor receptor (pdgfr) gene re-arrangements.  adult patients with advanced hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) with fip1l1-pdgfr rearrangement.

Linezolid Clonmel 2mg/ml solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

linezolid clonmel 2mg/ml solution for infusion

clonmel healthcare ltd - linezolid - solution for infusion - 2 milligram(s)/millilitre - other antibacterials; linezolid - antibacterials for systemic use - linezolid clonmel is indicated in adults for the treatment of community acquired pneumonia and nosocomial pneumonia when known or suspected to be caused by susceptible gram positive bacteria. in determining whether linezolid clonmel is an appropriate treatment, the results of microbiological tests or information on the prevalence of resistance to antibacterial agents among gram positive bacteria should be taken into consideration

DESLORATADINE CLONMEL 0.5 Mg/Ml Oral Solution Ireland - English - HPRA (Health Products Regulatory Authority)

desloratadine clonmel 0.5 mg/ml oral solution

clonmel healthcare ltd - desloratidine - oral solution - 0.5 mg/ml - other antihistamines for systemic use

Candesartan/Hydrochlorothiazide Clonmel 16mg / 12.5mg Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

candesartan/hydrochlorothiazide clonmel 16mg / 12.5mg tablets

clonmel healthcare ltd - candesartan cilexetil; hydrochlorothiazide - tablet - 16/12.5 milligram(s) - angiotensin ii antagonists and diuretics; candesartan and diuretics

Abacavir/Lamivudine Clonmel 600mg/300mg Film-coated Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

abacavir/lamivudine clonmel 600mg/300mg film-coated tablets

clonmel healthcare ltd - abacavir; lamivudine - film-coated tablet - 600/300 milligram(s) - antivirals for treatment of hiv infections, combinations; lamivudine and abacavir

Rasagiline Clonmel 1 mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

rasagiline clonmel 1 mg tablets

clonmel healthcare ltd - rasagiline - tablet - 1 milligram(s) - monoamine oxidase b inhibitors; rasagiline

ZOLEDRONIC ACID CLONMEL 4 MG/5ml Concentrate for Soln for Inf Ireland - English - HPRA (Health Products Regulatory Authority)

zoledronic acid clonmel 4 mg/5ml concentrate for soln for inf

clonmel healthcare ltd - zoledronic acid monohydrate - concentrate for soln for inf - 4 mg/5ml - biphosphonates